Maine Medicine Weekly Update - 12/17/2020  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Advisory Panel Recommends Moderna Vaccine, FDA Expected to Authorize Emergency Use
•  Update to Our Special Edition Wednesday Vaccine Newsletter
•  FDA Authorizes First OTC COVID-19 Test
•  Maine Public Radio Reports 32 COVID-19 Cases Linked To Bangor Hospital Outbreak
•  MaineCare Section 17 Assertive Community Treatment (ACT) Service Cap
•  Attention FQHCs and RHCs: Reimbursing Telehealth Services, CR 98696
•  Current FDA Drug Shortages
•  Not Much COVID Relief Movement from Congress
•  Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
•  PPE Available Through the MMA & ActionPPE
•  Maine Medical Association Enduring Education Opportunity
•  MICIS Opioid Prescribing Presentation & Individual Academic Detailing Sessions
•  Hanley's PELI Advanced Course Enrollment is OPEN!
•  A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
•  State Legislative Committees Announced
UPCOMING EVENTS
•  Upcoming Specialty Society Programs & Meetings
•  Webinar: “Radon Risk Reduction: The Current Policy Landscape in the US and the Maine Perspective” January 12, 2020
•  Caring for LGBTQ+ Youth in Maine - Emphasis on the 'T' - Half-day Symposium on Saturday, January 23
•  MOA VIRTUAL Midwinter Symposium - Feb 12-14, 2021
•  Maine CDC Annual Prevention Professionals Conference - March 2-3, 2021
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Behavioral Health Clinician
•  Psychiatric Nurse Practitioner
•  Physician (BC/BE in Family Medicine)

 

MICIS Opioid Prescribing Presentation & Individual Academic Detailing Sessions

Virtual sessions available Fall 2020 through Spring 2021. Presented by the Maine Independent Clinical Information Service (MICIS).

 

 MICIS Opioid Prescribing Presentation & Individual Academic Detailing Sessions

Virtual sessions available Fall 2020 through Spring 2021
Presented by the Maine Independent Clinical Information Service (MICIS)

Opioid Prescribing Presentation   For information and to schedule a presentation at your medical practice or hospital, visit www.micismaine.org.

Prescribing to Reduce Opioid Overdose Risk: How to Impact the Epidemic Within the Pandemic    
Learning Objectives:

  • Understand risk reduction in the context of opioid prescribing.
  • Obtain familiarity with the use of buprenorphine for opioid use disorder.
  • Describe recommendations for naloxone prescribing to increase patient safety.


Topics for Individual Academic Detailing Sessions    
Visit www.micismaine.org to schedule an Academic Detailing session.

Academic Detailing is peer-to-peer educational outreach which is designed to improve prescribing practices.  It is useful for improving quality of care and identifying priorities for change. 

Prescribers of opioids (physicians, nurse practitioners and physician assistants) may request a 1-hour Academic Detailing session which can be scheduled for any time of day.  There is no charge for the session.  MICIS is now scheduling individual 1-hour Academic Detailing sessions on these topics:

  • Opioid Prescribing in Maine 2020-2021
  • MAT Update for Maine 2020-2021
  • Moving Beyond Opioid and Benzodiazepine Combinations in Maine 2020-2021 

MICIS is a program of the Maine Medical Association.

The Maine Medical Education Trust designates this live internet activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and the Maine Independent Clinical Information Service (MICIS).  The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.